Table 3 Neoadjuvant/adjuvant treatment characteristics
S. no. | Variable (N = 33) | Number (percentage) |
|---|---|---|
1. | Neoadjuvant therapy | |
| Â | Received neoadjuvant therapy | 13 (40.62%) |
| Â | Did not receive neoadjuvant therapy | 19 (59.37%) |
2. | Response to neoadjuvant chemotherapy | No. of patients (percentage) |
a | Clinical partial response | 12 (92.30%) |
b | Pathological complete response | 0 (0%) |
c | Disease progression | 1 (7.6%) |
i | Tumour progression | 1 (7.6%) |
ii | Lymph nodal progression | 0 (0%) |
2. | Surgery | No. of patients (percentage) |
| Â | Modified radical mastectomy | 16 (50%) |
| Â | Breast conservation surgery | 16 (50%) |
3. | Adjuvant chemotherapy | No. of patients (percentage) |
| Â | Received | 29 (90.62%) |
| Â | None | 3 (9.30%) |
4 | Her2 positive received anti-her2/neu therapy | 10 (31.25%) |